Biopharma supply chain plans must navigate contradictory US policies

A granular analysis and approach is key to survival

drug

An employee checks capsules inside a Cadila Pharmaceutical company manufacturing unit in Ahmedabad, India. Not all countries and segments of the biopharmaceutical supply chain will be impacted equally by geopolitical uncertainties. © Reuters

Gopal Nadadur is senior vice president for South Asia, Sam Ide is vice president for China, and Alex Melillo is associate vice president for Japan at The Asia Group, a strategic advisory firm headquartered in Washington, D.C. Gopal is based in New Delhi and Sam and Alex are based in Washington, D.C.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.